Check out your Company Bowl for anonymous work chats.
Grifols has broken new ground in the fight against Alzheimer’s disease. We recently announced the success of AMBAR, a Phase IIb/III clinical trial aimed at slowing the progression of Alzheimer’s disease. Visit our new website to read more about the promising results, which show that AMBAR provides hope for a new treatment pathway for moderate Alzheimer's patients: http://glassdoor.com/slink.htm?key=vQJ28
